AbCellera Biologics Inc. ABCL Other Foreign Countries — Long-term assets
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsDesignatedToClosedBlockOtherLongTermInvestments.
The official record: AbCellera Biologics Inc.’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s other foreign countries — long-term assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s other foreign countries — long-term assets?
- AbCellera Biologics Inc. (ABCL) reported other foreign countries — long-term assets of $15.6M in Q4 2025.
- How has AbCellera Biologics Inc.'s other foreign countries — long-term assets changed year-over-year?
- AbCellera Biologics Inc.'s other foreign countries — long-term assets decreased by 15.2% year-over-year, from $18.4M to $15.6M.
- What does other foreign countries — long-term assets mean?
- Represents the total value of non-current assets, such as property, plant, equipment, and intangible assets, attributed to the company's operations within geographic regions classified as other foreign countries. This metric reflects the company's physical and strategic capital footprint outside of its primary operating markets. Monitoring this helps investors assess the geographic distribution of long-term investments and infrastructure supporting international business activities.